| ID | Assay | Related subunit | Celltype | Tissue | Disease | Treatment1 | Treatment2 | Study | Download1 | Download2 |
|---|---|---|---|---|---|---|---|---|---|---|
| CDBD00701 | ChIPseq | SA2 | Hep-G2 | Liver | Cancer | NT | NT | GSE25021 | ||
| CDBD00551 | ChIPseq | SA2 | Hela-Kyoto | Cervix | Cancer | NT | NT | GSE138405 | ||
| CDBD00550 | ChIPseq | SA2 | Hela-Kyoto | Cervix | Cancer | NT | NT | GSE138405 | ||
| CDBD00495 | ChIPseq | SA2 | HL-60 | Blood | Cancer | NT | NT | GSE131577 | ||
| CDBD00494 | ChIPseq | SA2 | HL-60 | Blood | Cancer | NT | NT | GSE131577 | ||
| CDBD00475 | ChIPseq | SA2 | Hela-Kyoto | Cervix | Cancer | NT | NT | GSE126990 | ||
| CDBD00392 | ChIPseq | SA2 | RT-112 | Bladder | Cancer | NT | NT | GSE111913 | ||
| CDBD00391 | ChIPseq | SA2 | RT-112 | Bladder | Cancer | NT | NT | GSE111913 | ||
| CDBD00387 | ChIPseq | SA2 | OCI-AML-3 | Blood | Cancer | NT | siSA2 | GSE111537 | ||
| CDBD00386 | ChIPseq | SA2 | OCI-AML-3 | Blood | Cancer | NT | NT | GSE111537 |